Primary stroke prevention

American Journal of Nursing

Volumn 106, Issue 11, 2006, Pages 40-50

  Sauerbeck, Laura R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750495577     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200611000-00013     Document Type: Review

References (53)

1. National Stroke Association. The stroke/brain attack reporter's handbook. Englewood, CO: The Association; 1995.
2. Mackay J, et al. The atlas of heart disease and stroke. Geneva: World Health Organization; 2004.
3. Seshadri S, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006;37(2):345-50.
4. Thom T, et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;113(6):e85-151.
5. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990;21(4):637-76.
6. Goldstein LB, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2001;32(1):280-99.
7. Miller ET, Spilker J. Readiness to change and brief educational interventions: successful strategies to reduce stroke risk. J Neurosci Nurs 2003;35(4):215-22.
8. Sauerbeck LR, et al. Smoking cessation after stroke: education and its effect on behavior. J Neurosci Nurs 2005;37(6):316-9, 325.
9. Schneider AT, et al. Trends in community knowledge of the warning signs and risk factors for stroke. JAMA 2003;289(3):343-6.
10. Kissela B, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke 2004;35(2):426-31.
11. Centers for Disease Control and Prevention. Differences in disability among black and white stroke survivors - United States, 2000-2001. MMWR Morb Mortal Wkly Rep 2005;54(1):3-6.
12. Morgenstern LB, et al. Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol 2004;160(4):376-83.
13. Meschia JF. Ischemic stroke as a complex genetic disorder. Semin Neurol 2006;26(1):49-56.
14. Woo D, et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 2002;33(5):1190-5.
15. Kissela BM, et al. Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke 2002;33(5):1321-6.
16. Markus HS, Alberts MJ. Update on genetics of stroke and cerebrovascular disease 2005. Stroke 2006;37(2):288-90.
17. Lawes CM, et al. Blood pressure and stroke: an overview of published reviews. Stroke 2004;35(4):1024.
18. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2001;345(7):479-86.
19. Vasan RS, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 2002;287(8):1003-10.
20. Chobanian AV, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289(19):2560-72.
21. Kase CS, et al. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator. Am J Med 1992;92(4):384-90.
22. Wolf PA, et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22(8):983-8.
23. Li C, et al. Blood pressure control and risk of stroke: a population-based prospective cohort study. Stroke 2005;36(4):725-30.
24. Connolly S, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006;367(9526):1903-12.
25. Caro JJ, et al. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice. CMAJ 1999;161(5):493-7.
26. Currie CJ, et al. Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin. Heart 2006;92(2):196-200.
27. Friberg L, et al. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J 2006;27(16):1954-64.
28. Choudhry NK, et al. Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Am J Med 2006;119(7):607-15.
29. DeWilde S, et al. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 2006;92(8):1064-70.
30. Reynolds MR, et al. Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL Registry. Am J Cardiol 2006;97(4):538-43.
31. Pearson TA, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106(3):388-91.
32. American Diabetes Association. Redefining diabetes control. Diabetes and Cardiovascular Disease Review 2002(1):1-3. http://www.diabetes.org/uedocuments/ DCVDissue1.pdf.
33. Kurl S, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006;37(3):806-11.
34. Najarian RM, et al. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med 2006;166(1):106-11.
35. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
36. Sacco RL, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 2006;37(2):577-617.
37. Bushnell CD, et al. Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke 2006;37(6):1427-31.
38. Baigent C, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366(9493):1267-78.
39. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360(9326):7-22.
40. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995;273(18):1421-8.
41. Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. National Institute of Neurological Disorders and Stroke, Stroke and Trauma Division. North American Symptomatic Carotid Endarterectomy Trial (NASCET) investigators. Stroke 1991;22(6):816-7.
42. Hanley D, et al. Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: a guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention. J Stroke Cerebrovasc Dis 2004;13(5):196-207.
43. Moore WS, et al. Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the Ad Hoc Committee, American Heart Association. Circulation 1995;91(2):566-79.
44. Giles MF, et al. Patient behavior immediately after transient ischemic attack according to clinical characteristics, perception of the event, and predicted risk of stroke. Stroke 2006;37(5):1254-60.
45. Rothwell PM, et al. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 2006;5(4):323-31.
46. Kothari R, et al. Acute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med 1999;33(1):3-8.
47. Kothari R, et al. Patients' awareness of stroke signs, symptoms, and risk factors. Stroke 1997;28(10):1871-5.
48. Adams H, et al. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005;36(4):916-23.
49. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989;298(6676):789-94.
50. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 2005;111(20):2684-98.
51. U.S. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Rockville, MD: The Department; 2004.
52. Brown DW, et al. Inpatient smoking-cessation counseling and all-cause mortality among the elderly. Am J Prev Med 2004;26(2):112-8.
53. Suk SH, et al. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2003;34(7):1586-92.